{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T22:41:41Z","timestamp":1782254501704,"version":"3.54.5"},"reference-count":133,"publisher":"Portland Press Ltd.","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1,28]]},"abstract":"<jats:p>Mycobacterium tuberculosis (MTB) is the etiologic agent of tuberculosis (TB) in humans, an infectious disease that continues to be a significant global health concern. The long-term use of multiple anti-tubercular agents may result in patient non-compliance and increased drug toxicity, which could contribute to the emergence of drug-resistant MTB strains that are not susceptible even to second-line available drugs. It is therefore imperative that new antitubercular drugs and vaccines are developed. The peculiar traits of MTB, such as the biochemical and structural features of vital metabolic pathways, can be assessed to identify possible targets for drug development. Enzymes involved in pyrimidine metabolism may be suitable drug targets for TB, given that this pathway is essential for mycobacteria and comprises enzymes that differ from those found in humans. Here, we focused on reviewing the state of the art concerning the therapeutic opportunities presented by the pyrimidine biosynthetic pathway (PBP) as a potential source of enzymes that could be targeted for the treatment of TB. We selected essential enzymes belonging to the PBP for which we identified the existence of a drug discovery pipeline at both the preclinical and clinical levels. Moreover, we emphasize the biochemical and structural characteristics that are pertinent to the development of pharmaceutical agents. These include the molecular details that can ensure selectivity towards the pathogen\u2019s proteins.<\/jats:p>","DOI":"10.1042\/bst20253113","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T09:07:51Z","timestamp":1768295271000},"page":"37-56","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Targeting opportunities presented by the pyrimidine biosynthesis pathway in\n                    <i>Mycobacterium tuberculosis:<\/i>\n                    a brief review"],"prefix":"10.1042","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3827-7243","authenticated-orcid":false,"given":"Marta","family":"Alberti","sequence":"first","affiliation":[{"name":"1Department of Pharmaceutical Sciences, Via G. Bovio 6, University of Piemonte Orientale, Novara, 28100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2159-3314","authenticated-orcid":false,"given":"Riccardo","family":"Miggiano","sequence":"additional","affiliation":[{"name":"1Department of Pharmaceutical Sciences, Via G. Bovio 6, University of Piemonte Orientale, Novara, 28100, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"2026012903565481000_BST-2025-3113C1","unstructured":"Global tuberculosis report 2024\n          . (2024) Geneva: World Health Organization"},{"key":"2026012903565481000_BST-2025-3113C2","doi-asserted-by":"crossref","first-page":"1194923","DOI":"10.3389\/fimmu.2023.1194923","article-title":"Mycobacterium tuberculosis cell-wall and antimicrobial peptides: a mission impossible?","volume":"14","author":"Jacobo-Delgado","year":"2023","journal-title":"Front. Immunol."},{"key":"2026012903565481000_BST-2025-3113C3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jgg.2015.04.004","article-title":"Pyrimidine metabolism: dynamic and versatile pathways in pathogens and cellular development","volume":"42","author":"Garavito","year":"2015","journal-title":"J. Genet. Genomics"},{"key":"2026012903565481000_BST-2025-3113C4","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/br.34.3.278-343.1970","article-title":"Pyrimidine metabolism in microorganisms","volume":"34","author":"O\u2019Donovan","year":"1970","journal-title":"Bacteriol. Rev."},{"key":"2026012903565481000_BST-2025-3113C5","doi-asserted-by":"crossref","first-page":"29682","DOI":"10.1074\/jbc.270.50.29682","article-title":"Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors","volume":"270","author":"Fairbanks","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2026012903565481000_BST-2025-3113C6","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.2174\/092986711795029555","article-title":"Pyrimidine salvage pathway in Mycobacterium tuberculosis","volume":"18","author":"Villela","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"2026012903565481000_BST-2025-3113C8","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"2026012903565481000_BST-2025-3113C9","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/cells11040739","article-title":"Re-discovery of pyrimidine salvage as target in cancer therapy","volume":"11","author":"Walter","year":"2022","journal-title":"Cells"},{"key":"2026012903565481000_BST-2025-3113C10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s00284-007-9050-3","article-title":"Pathways of pyrimidine salvage in Pseudomonas and former Pseudomonas: detection of recycling enzymes using high-performance liquid chromatography","volume":"56","author":"Beck","year":"2008","journal-title":"Curr. Microbiol."},{"key":"2026012903565481000_BST-2025-3113C11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0952-7915(00)00236-3","article-title":"Immune responses to intracellular bacteria","volume":"13","author":"Raupach","year":"2001","journal-title":"Curr. Opin. Immunol."},{"key":"2026012903565481000_BST-2025-3113C12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1099\/mic.0.2007\/012872-0","article-title":"Nutrient acquisition by mycobacteria","volume":"154","author":"Niederweis","year":"2008","journal-title":"Microbiology (Reading, Engl.)"},{"key":"2026012903565481000_BST-2025-3113C13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cell.2008.11.014","article-title":"The role of the granuloma in expansion and dissemination of early tuberculous infection","volume":"136","author":"Davis","year":"2009","journal-title":"Cell"},{"key":"2026012903565481000_BST-2025-3113C14","doi-asserted-by":"crossref","first-page":"e00070-19","DOI":"10.1128\/mSystems.00070-19","article-title":"Genomewide assessment of mycobacterium tuberculosis conditionally essential metabolic pathways","volume":"4","author":"Minato","year":"2019","journal-title":"mSystems"},{"key":"2026012903565481000_BST-2025-3113C15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1021\/ar800114w","article-title":"Keeping uracil out of DNA: physiological role, structure and catalytic mechanism of dUTPases","volume":"42","author":"V\u00e9rtessy","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"2026012903565481000_BST-2025-3113C16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jmb.2004.06.028","article-title":"Crystal structure of the Mycobacterium tuberculosis dUTPase: insights into the catalytic mechanism","volume":"341","author":"Chan","year":"2004","journal-title":"J. Mol. Biol."},{"key":"2026012903565481000_BST-2025-3113C17","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbrc.2008.05.130","article-title":"Active site of mycobacterial dUTPase: structural characteristics and a built-in sensor","volume":"373","author":"Varga","year":"2008","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2026012903565481000_BST-2025-3113C18","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.1093\/nar\/gkq584","article-title":"Aromatic stacking between nucleobase and enzyme promotes phosphate ester hydrolysis in dUTPase","volume":"38","author":"Pecsi","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"2026012903565481000_BST-2025-3113C19","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1016\/j.febslet.2010.05.018","article-title":"Direct contacts between conserved motifs of different subunits provide major contribution to active site organization in human and mycobacterial dUTPases","volume":"584","author":"Tak\u00e1cs","year":"2010","journal-title":"FEBS Lett."},{"key":"2026012903565481000_BST-2025-3113C20","unstructured":"RCSB PDB\n          . (2024) 4GCY: Structure of Mycobacterium tuberculosis dUTPase H21W mutant. https:\/\/www.rcsb.org\/structure\/4GCY"},{"key":"2026012903565481000_BST-2025-3113C21","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1021\/jacs.6b09012","article-title":"Structural characterization of arginine fingers: identification of an arginine finger for the pyrophosphatase dUTPases","volume":"138","author":"Nagy","year":"2016","journal-title":"J. Am. Chem. Soc."},{"key":"2026012903565481000_BST-2025-3113C22","unstructured":"RCSB PDB\n          . (2024) 8CGA: Structure of Mycobacterium tuberculosis dUTPase delta 133A-137S mutant. https:\/\/www.rcsb.org\/structure\/8CGA"},{"key":"2026012903565481000_BST-2025-3113C23","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.jmb.2007.11.099","article-title":"Mechanism of dTTP inhibition of the bifunctional dCTP deaminase:dUTPase encoded by Mycobacterium tuberculosis","volume":"376","author":"Helt","year":"2008","journal-title":"J. Mol. Biol."},{"key":"2026012903565481000_BST-2025-3113C24","doi-asserted-by":"crossref","first-page":"757914","DOI":"10.3389\/fmicb.2021.757914","article-title":"Screening and identification of a novel anti-tuberculosis compound that targets deoxyuridine 5\u2032-triphosphate nucleotidohydrolase","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Microbiol."},{"key":"2026012903565481000_BST-2025-3113C25","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1110\/ps.45701","article-title":"Thymidylate kinase of Mycobacterium tuberculosis: a chimera sharing properties common to eukaryotic and bacterial enzymes","volume":"10","author":"Munier-Lehmann","year":"2001","journal-title":"Protein Sci."},{"key":"2026012903565481000_BST-2025-3113C26","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1006\/jmbi.2001.5286","article-title":"Sugar specificity of bacterial CMP kinases as revealed by crystal structures and mutagenesis of Escherichia coli enzyme","volume":"315","author":"Bertrand","year":"2002","journal-title":"J. Mol. Biol."},{"key":"2026012903565481000_BST-2025-3113C27","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1016\/S0960-894X(03)00643-7","article-title":"Thymidine and thymidine-5\u2019-O-monophosphate analogues as inhibitors of Mycobacterium tuberculosis thymidylate kinase","volume":"13","author":"Vanheusden","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"2026012903565481000_BST-2025-3113C28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/jmbi.2001.4843","article-title":"X-ray structure of TMP kinase from Mycobacterium tuberculosis complexed with TMP at 1.95 A resolution","volume":"311","author":"Li de la Sierra","year":"2001","journal-title":"J. Mol. Biol."},{"key":"2026012903565481000_BST-2025-3113C29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1107\/S0907444902002135","article-title":"Cryophotolysis of caged compounds: a technique for trapping intermediate states in protein crystals","volume":"58","author":"Ursby","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"2026012903565481000_BST-2025-3113C30","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0022-2836(03)00202-X","article-title":"Mycobacterium tuberculosis thymidylate kinase: structural studies of intermediates along the reaction pathway","volume":"327","author":"Fioravanti","year":"2003","journal-title":"J. Mol. Biol."},{"key":"2026012903565481000_BST-2025-3113C31","doi-asserted-by":"crossref","first-page":"4963","DOI":"10.1074\/jbc.M209630200","article-title":"Enzymatic and structural analysis of inhibitors designed against Mycobacterium tuberculosis thymidylate kinase. New insights into the phosphoryl transfer mechanism","volume":"278","author":"Haouz","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2026012903565481000_BST-2025-3113C32","author":"Naik","year":"2015","journal-title":"Structure guided lead generation for M. tuberculosis thymidylate kinase (Mtb TMK): discovery of 3-cyanopyridone"},{"key":"2026012903565481000_BST-2025-3113C33","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1021\/acs.jmedchem.7b01570","article-title":"Structure guided lead generation toward nonchiral m. tuberculosis thymidylate kinase inhibitors","volume":"61","author":"Song","year":"2018","journal-title":"J. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C34","doi-asserted-by":"crossref","first-page":"112659","DOI":"10.1016\/j.ejmech.2020.112659","article-title":"Endeavors towards transformation of M. tuberculosis thymidylate kinase (MtbTMPK) inhibitors into potential antimycobacterial agents","volume":"206","author":"Jian","year":"2020","journal-title":"Eur. J. Med. Chem"},{"key":"2026012903565481000_BST-2025-3113C35","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/cmdc.200600028","article-title":"Synthesis and biological evaluation of bicyclic nucleosides as inhibitors of M. tuberculosis thymidylate kinase","volume":"1","author":"Van Daele","year":"2006","journal-title":"ChemMedChem"},{"key":"2026012903565481000_BST-2025-3113C36","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1021\/bi0484163","article-title":"The Crystal Structure of Mycobacterium tuberculosis Thymidylate Kinase in Complex with 3\u2018-Azidodeoxythymidine Monophosphate Suggests a Mechanism for Competitive Inhibition ,","volume":"44","author":"Fioravanti","year":"2005","journal-title":"Biochemistry"},{"key":"2026012903565481000_BST-2025-3113C37","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1021\/jm040847w","article-title":"Discovery of bicyclic thymidine analogues as selective and high-affinity inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase","volume":"47","author":"Vanheusden","year":"2004","journal-title":"J. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C38","doi-asserted-by":"crossref","first-page":"53123","DOI":"10.1074\/jbc.M311209200","article-title":"Unique mechanism of action of the thiourea drug isoxyl on Mycobacterium tuberculosis","volume":"278","author":"Phetsuksiri","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2026012903565481000_BST-2025-3113C39","doi-asserted-by":"crossref","first-page":"7603","DOI":"10.1016\/j.bmc.2011.10.021","article-title":"Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase","volume":"19","author":"Van Poecke","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C40","doi-asserted-by":"crossref","first-page":"10010","DOI":"10.1021\/jm3011806","article-title":"Discovery of selective and potent inhibitors of gram-positive bacterial thymidylate kinase (TMK)","volume":"55","author":"Mart\u00ednez-Botella","year":"2012","journal-title":"J. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1021\/acsmedchemlett.8b00177","article-title":"Identification of N-Benzyl 3,5-Dinitrobenzamides Derived from PBTZ169 as Antitubercular Agents","volume":"9","author":"Li","year":"2018","journal-title":"ACS Med. Chem. Lett."},{"key":"2026012903565481000_BST-2025-3113C42","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.1016\/j.bmc.2016.08.041","article-title":"Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents","volume":"24","author":"Song","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejmech.2017.05.044","article-title":"Design, synthesis and antimycobacterial activity of novel imidazo[1,2-a]pyridine-3-carboxamide derivatives","volume":"137","author":"Lv","year":"2017","journal-title":"Eur. J. Med. Chem"},{"key":"2026012903565481000_BST-2025-3113C44","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1021\/acsmedchemlett.6b00330","article-title":"Identification of N-(2-Phenoxyethyl)imidazo[1,2-a]pyridine-3-carboxamides as New Antituberculosis Agents","volume":"7","author":"Wu","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"2026012903565481000_BST-2025-3113C45","doi-asserted-by":"crossref","first-page":"e1000645","DOI":"10.1371\/journal.ppat.1000645","article-title":"High content screening identifies decaprenyl-phosphoribose 2\u2019 epimerase as a target for intracellular antimycobacterial inhibitors","volume":"5","author":"Christophe","year":"2009","journal-title":"PLoS Pathog."},{"key":"2026012903565481000_BST-2025-3113C46","doi-asserted-by":"crossref","first-page":"113784","DOI":"10.1016\/j.ejmech.2021.113784","article-title":"Structure-aided optimization of non-nucleoside M. tuberculosis thymidylate kinase inhibitors","volume":"225","author":"Song","year":"2021","journal-title":"Eur. J. Med. Chem"},{"key":"2026012903565481000_BST-2025-3113C47","doi-asserted-by":"crossref","first-page":"114946","DOI":"10.1016\/j.ejmech.2022.114946","article-title":"Pyrimidine derivatives with antitubercular activity","volume":"246","author":"Finger","year":"2023","journal-title":"Eur. J. Med. Chem"},{"key":"2026012903565481000_BST-2025-3113C48","doi-asserted-by":"crossref","first-page":"2386668","DOI":"10.1080\/14756366.2024.2386668","article-title":"Challenging the Biginelli scaffold to surpass the first line antitubercular drugs: Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibition activity and molecular modelling studies","volume":"39","author":"El-Shoukrofy","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C49","doi-asserted-by":"crossref","first-page":"55853","DOI":"10.1039\/C4RA06917J","article-title":"Quantitative structure\u2013activity relationships and design of thymine-like inhibitors of thymidine monophosphate kinase of Mycobacterium tuberculosis with favourable pharmacokinetic profiles","volume":"4","author":"Keita","year":"2014","journal-title":"RSC Adv"},{"key":"2026012903565481000_BST-2025-3113C50","doi-asserted-by":"crossref","first-page":"e8769","DOI":"10.1371\/journal.pone.0008769","article-title":"Mycobacterial nucleoside diphosphate kinase blocks phagosome maturation in murine RAW 264.7 macrophages","volume":"5","author":"Sun","year":"2010","journal-title":"PLoS ONE"},{"key":"2026012903565481000_BST-2025-3113C51","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1046\/j.1432-1033.2003.03402.x","article-title":"Cytotoxic activity of nucleoside diphosphate kinase secreted from Mycobacterium tuberculosis","volume":"270","author":"Chopra","year":"2003","journal-title":"Eur. J. Biochem."},{"key":"2026012903565481000_BST-2025-3113C52","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1080\/07391102.2019.1595150","article-title":"Mycobacterium tuberculosis nucleoside diphosphate kinase shows interaction with putative ATP binding cassette (ABC) transporter, Rv1273c","volume":"38","author":"Gupta","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"2026012903565481000_BST-2025-3113C53","doi-asserted-by":"crossref","first-page":"43595","DOI":"10.1074\/jbc.M401704200","article-title":"Amino acid residues involved in autophosphorylation and phosphotransfer activities are distinct in nucleoside diphosphate kinase from Mycobacterium tuberculosis","volume":"279","author":"Tiwari","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2026012903565481000_BST-2025-3113C54","doi-asserted-by":"crossref","first-page":"e57867","DOI":"10.1371\/journal.pone.0057867","article-title":"Intersubunit ionic interactions stabilize the nucleoside diphosphate kinase of Mycobacterium tuberculosis","volume":"8","author":"Georgescauld","year":"2013","journal-title":"PLoS ONE"},{"key":"2026012903565481000_BST-2025-3113C55","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1093\/nar\/gki568","article-title":"Nucleoside diphosphate kinase from Mycobacterium tuberculosis cleaves single strand DNA within the human c-myc promoter in an enzyme-catalyzed reaction","volume":"33","author":"Kumar","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"2026012903565481000_BST-2025-3113C56","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/prot.10113","article-title":"X-ray structure of Mycobacterium tuberculosis nucleoside diphosphate kinase","volume":"47","author":"Chen","year":"2002","journal-title":"Proteins"},{"key":"2026012903565481000_BST-2025-3113C57","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1046\/j.1365-2958.1998.00846.x","article-title":"Nucleoside diphosphate kinase: role in bacterial growth, virulence, cell signalling and polysaccharide synthesis","volume":"28","author":"Chakrabarty","year":"1998","journal-title":"Mol. Microbiol."},{"key":"2026012903565481000_BST-2025-3113C58","doi-asserted-by":"crossref","first-page":"530","DOI":"10.3390\/vaccines12050530","article-title":"Live attenuated vaccines against tuberculosis: targeting the disruption of genes encoding the secretory proteins of mycobacteria","volume":"12","author":"Veerapandian","year":"2024","journal-title":"Vaccines (Basel)"},{"key":"2026012903565481000_BST-2025-3113C59","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1072113","article-title":"An alternative flavin-dependent mechanism for thymidylate synthesis","volume":"297","author":"Myllykallio","year":"2002","journal-title":"Science"},{"key":"2026012903565481000_BST-2025-3113C60","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1021\/bi9815896","article-title":"Structure-based design of inhibitors specific for bacterial thymidylate synthase","volume":"38","author":"Stout","year":"1999","journal-title":"Biochemistry"},{"key":"2026012903565481000_BST-2025-3113C61","doi-asserted-by":"crossref","first-page":"107447","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: Past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"2026012903565481000_BST-2025-3113C62","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2217\/14796694.1.6.733","article-title":"Clinical activity of pemetrexed: a multitargeted antifolate anticancer agent","volume":"1","author":"Solomon","year":"2005","journal-title":"Future Oncol."},{"key":"2026012903565481000_BST-2025-3113C63","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.clinre.2013.11.006","article-title":"Raltitrexed-based chemotherapy for advanced colorectal cancer","volume":"38","author":"Liu","year":"2014","journal-title":"Clin. Res. Hepatol. Gastroenterol"},{"key":"2026012903565481000_BST-2025-3113C64","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1007\/s00280-003-0625-9","article-title":"Thymidylate synthase inhibitors as anticancer agents: from bench to bedside","volume":"52 Suppl 1","author":"Chu","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"2026012903565481000_BST-2025-3113C65","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1021\/jm9900016","article-title":"Phthalein derivatives as a new tool for selectivity in thymidylate synthase inhibition","volume":"42","author":"Costi","year":"1999","journal-title":"J. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C66","doi-asserted-by":"crossref","first-page":"e2237","DOI":"10.1371\/journal.pone.0002237","article-title":"Kinetics and ligand-binding preferences of Mycobacterium tuberculosis thymidylate synthases, ThyA and ThyX","volume":"3","author":"Hunter","year":"2008","journal-title":"PLoS ONE"},{"key":"2026012903565481000_BST-2025-3113C67","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1158\/1078-0432.CCR-08-0864","article-title":"Phase I, pharmacokinetic and biological correlative study of OSI-7904L, a novel liposomal thymidylate synthase inhibitor, and cisplatin in patients with solid tumors","volume":"14","author":"Ricart","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"2026012903565481000_BST-2025-3113C68","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jmb.2005.07.071","article-title":"Structure of the Mycobacterium tuberculosis flavin dependent thymidylate synthase (MtbThyX) at 2.0A resolution","volume":"352","author":"Sampathkumar","year":"2005","journal-title":"J. Mol. Biol."},{"key":"2026012903565481000_BST-2025-3113C69","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.tube.2014.12.003","article-title":"Increasing the structural coverage of tuberculosis drug targets","volume":"95","author":"Baugh","year":"2015","journal-title":"Tuberculosis (Edinb)"},{"key":"2026012903565481000_BST-2025-3113C70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmb.2006.04.061","article-title":"NADP+ expels both the co-factor and a substrate analog from the Mycobacterium tuberculosis ThyX active site: opportunities for anti-bacterial drug design","volume":"360","author":"Sampathkumar","year":"2006","journal-title":"J. Mol. Biol."},{"key":"2026012903565481000_BST-2025-3113C71","doi-asserted-by":"crossref","first-page":"4847","DOI":"10.1021\/jm2004688","article-title":"Synthesis and evaluation of 5-substituted 2\u2019-deoxyuridine monophosphate analogues as inhibitors of flavin-dependent thymidylate synthase in Mycobacterium tuberculosis","volume":"54","author":"K\u00f6gler","year":"2011","journal-title":"J. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C72","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1002\/cmdc.201300146","article-title":"Discovery of an acyclic nucleoside phosphonate that inhibits Mycobacterium tuberculosis ThyX based on the binding mode of a 5-alkynyl substrate analogue","volume":"8","author":"Parchina","year":"2013","journal-title":"ChemMedChem"},{"key":"2026012903565481000_BST-2025-3113C73","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.1016\/j.bmc.2015.09.053","article-title":"Synthesis and evaluation of C-5 modified 2\u2019-deoxyuridine monophosphates as inhibitors of M. tuberculosis thymidylate synthase","volume":"23","author":"Alexandrova","year":"2015","journal-title":"Bioorg. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C74","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/cmdc.201800739","article-title":"Synthesis and structure-activity relationship studies of benzo[b][1,4]oxazin-3(4H)-one Analogues as inhibitors of mycobacterial thymidylate synthase\u2005X","volume":"14","author":"Modranka","year":"2019","journal-title":"ChemMedChem"},{"key":"2026012903565481000_BST-2025-3113C75","doi-asserted-by":"crossref","first-page":"980844","DOI":"10.3389\/fcimb.2022.980844","article-title":"Uncovering interactions between mycobacterial respiratory complexes to target drug-resistant Mycobacterium tuberculosis","volume":"12","author":"McNeil","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"2026012903565481000_BST-2025-3113C76","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1128\/jb.174.17.5647-5653.1992","article-title":"dcd (dCTP deaminase) gene of Escherichia coli: mapping, cloning, sequencing, and identification as a locus of suppressors of lethal dut (dUTPase) mutations","volume":"174","author":"Wang","year":"1992","journal-title":"J. Bacteriol."},{"key":"2026012903565481000_BST-2025-3113C77","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1054\/bjoc.2001.1921","article-title":"The ability to accumulate deoxyuridine triphosphate and cellular response to thymidylate synthase (TS) inhibition","volume":"85","author":"Webley","year":"2001","journal-title":"Br. J. Cancer"},{"key":"2026012903565481000_BST-2025-3113C78","doi-asserted-by":"crossref","first-page":"33882","DOI":"10.1074\/jbc.M401989200","article-title":"Substrate-induced conformational changes in human UMP\/CMP kinase","volume":"279","author":"Segura-Pe\u00f1a","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2026012903565481000_BST-2025-3113C79","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1002\/ejoc.200300177","article-title":"Mycobacterium tuberculosis Thymidine Monophosphate Kinase Inhibitors: Biological Evaluation and Conformational Analysis of 2\u2032- and 3\u2032-Modified Thymidine Analogues","volume":"2003","author":"Van Rompaey","year":"2003","journal-title":"European J. Org. Chem."},{"key":"2026012903565481000_BST-2025-3113C80","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2958.2003.03425.x","article-title":"Genes required for mycobacterial growth defined by high density mutagenesis","volume":"48","author":"Sassetti","year":"2003","journal-title":"Mol. Microbiol."},{"key":"2026012903565481000_BST-2025-3113C81","doi-asserted-by":"crossref","first-page":"e1002251","DOI":"10.1371\/journal.ppat.1002251","article-title":"High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism","volume":"7","author":"Griffin","year":"2011","journal-title":"PLoS Pathog."},{"key":"2026012903565481000_BST-2025-3113C82","doi-asserted-by":"crossref","first-page":"e02133-16","DOI":"10.1128\/mBio.02133-16","article-title":"Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis","volume":"8","author":"DeJesus","year":"2017","journal-title":"MBio"},{"key":"2026012903565481000_BST-2025-3113C83","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0167-4838(88)90014-3","article-title":"Purification and properties of aspartate transcarbamylase from Mycobacterium smegmatis","volume":"953","author":"Masood","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"2026012903565481000_BST-2025-3113C84","doi-asserted-by":"crossref","first-page":"e202300279","DOI":"10.1002\/cmdc.202300279","article-title":"Inhibitors of Aspartate Transcarbamoylase Inhibit Mycobacterium tuberculosis Growth","volume":"18","author":"Du","year":"2023","journal-title":"ChemMedChem"},{"key":"2026012903565481000_BST-2025-3113C85","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-5956-10-14","article-title":"Analysis of intracellular expressed proteins of Mycobacterium tuberculosis clinical isolates","volume":"10","author":"Singhal","year":"2012","journal-title":"Proteome Sci."},{"key":"2026012903565481000_BST-2025-3113C86","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1021\/acs.jnatprod.5c00887","article-title":"Arzanol Inhibits Human Dihydroorotate Dehydrogenase and Shows Antiviral Activity","volume":"88","author":"Alberti","year":"2025","journal-title":"J. Nat. Prod."},{"key":"2026012903565481000_BST-2025-3113C87","doi-asserted-by":"crossref","first-page":"130378","DOI":"10.1016\/j.bbagen.2023.130378","article-title":"Kinetic and structural studies of Mycobacterium tuberculosis dihydroorotate dehydrogenase reveal new insights into class 2 DHODH inhibition","volume":"1867","author":"Teixeira","year":"2023","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"2026012903565481000_BST-2025-3113C88","unstructured":"RCSB PDB\n          . (2024) 4XQ6: CRYSTAL STRUCTURE OF DIHYDROOROTATE DEHYDROGENSE from MYCOBACTERIUM TUBERCULOSIS. https:\/\/www.rcsb.org\/structure\/4XQ6"},{"key":"2026012903565481000_BST-2025-3113C89","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1002\/1873-3468.14680","article-title":"Biochemical characterization of Mycobacterium tuberculosis dihydroorotate dehydrogenase and identification of a selective inhibitor","volume":"597","author":"Alberti","year":"2023","journal-title":"FEBS Lett."},{"key":"2026012903565481000_BST-2025-3113C90","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41598-017-01057-z","article-title":"Structural investigations on orotate phosphoribosyltransferase from Mycobacterium tuberculosis, a key enzyme of the de novo pyrimidine biosynthesis","volume":"7","author":"Donini","year":"2017","journal-title":"Sci. Rep."},{"key":"2026012903565481000_BST-2025-3113C91","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1016\/S0006-2952(99)00231-2","article-title":"Pyrimidine nucleobase ligands of orotate phosphoribosyltransferase from Toxoplasma gondii","volume":"58","author":"Javaid","year":"1999","journal-title":"Biochem. Pharmacol"},{"key":"2026012903565481000_BST-2025-3113C92","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.chembiol.2015.05.016","article-title":"Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG","volume":"22","author":"Mori","year":"2015","journal-title":"Chem. Biol."},{"key":"2026012903565481000_BST-2025-3113C93","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.ejmech.2018.03.020","article-title":"Drug discovery in tuberculosis. New drug targets and antimycobacterial agents","volume":"150","author":"Campani\u00e7o","year":"2018","journal-title":"Eur. J. Med. Chem"},{"key":"2026012903565481000_BST-2025-3113C94","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.tube.2009.05.008","article-title":"High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv","volume":"89","author":"Ananthan","year":"2009","journal-title":"Tuberculosis (Edinb)."},{"key":"2026012903565481000_BST-2025-3113C95","doi-asserted-by":"crossref","first-page":"10253","DOI":"10.3390\/ijms221910253","article-title":"Pyrimidine Biosynthetic Enzyme CAD: Its Function, Regulation, and Diagnostic Potential","volume":"22","author":"Li","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"2026012903565481000_BST-2025-3113C96","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.str.2017.04.012","article-title":"Structural Insight into the Core of CAD, the Multifunctional Protein Leading De Novo Pyrimidine Biosynthesis","volume":"25","author":"Moreno-Morcillo","year":"2017","journal-title":"Structure"},{"key":"2026012903565481000_BST-2025-3113C97","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1021\/bi00429a040","article-title":"Analysis of the kinetic mechanism of the bovine liver mitochondrial dihydroorotate dehydrogenase","volume":"28","author":"Hines","year":"1989","journal-title":"Biochemistry"},{"key":"2026012903565481000_BST-2025-3113C98","doi-asserted-by":"crossref","first-page":"42352","DOI":"10.1074\/jbc.M307399200","article-title":"Crystal Structure of Mycobacterium tuberculosis MenB, a Key Enzyme in Vitamin K2 Biosynthesis","volume":"278","author":"Truglio","year":"2003","journal-title":"Journal of Biological Chemistry"},{"key":"2026012903565481000_BST-2025-3113C99","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0969-2126(02)00831-6","article-title":"E. coli dihydroorotate dehydrogenase reveals structural and functional distinctions between different classes of dihydroorotate dehydrogenases","volume":"10","author":"N\u00f8rager","year":"2002","journal-title":"Structure"},{"key":"2026012903565481000_BST-2025-3113C100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/rep.0.1230757","article-title":"Detection and location of the enzymes of de novo pyrimidine biosynthesis in mammalian spermatozoa","volume":"123","author":"Carrey","year":"2002","journal-title":"Reproduction"},{"key":"2026012903565481000_BST-2025-3113C101","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1080\/15476286.2022.2146919","article-title":"Inhibition of mitochondrial complex III or dihydroorotate dehydrogenase (DHODH) triggers formation of poly(A)+ RNA foci adjacent to nuclear speckles following activation of ATM (ataxia telangiectasia mutated)","volume":"19","author":"Miyake","year":"2022","journal-title":"RNA Biol."},{"key":"2026012903565481000_BST-2025-3113C102","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2174\/1574892812666171108124218","article-title":"Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy","volume":"13","author":"Lolli","year":"2018","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"2026012903565481000_BST-2025-3113C103","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1055\/s-0031-1296169","article-title":"Human dihydroorotate dehydrogenase inhibitors, a novel approach for the treatment of autoimmune and inflammatory diseases","volume":"61","author":"Leban","year":"2011","journal-title":"Arzneimittelforschung"},{"key":"2026012903565481000_BST-2025-3113C104","doi-asserted-by":"crossref","first-page":"114176","DOI":"10.1016\/j.ejmech.2022.114176","article-title":"Recent advances of human dihydroorotate dehydrogenase inhibitors for cancer therapy: Current development and future perspectives","volume":"232","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C105","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.cmet.2018.10.014","article-title":"Reactivation of Dihydroorotate Dehydrogenase-Driven Pyrimidine Biosynthesis Restores Tumor Growth of Respiration-Deficient Cancer Cells","volume":"29","author":"Bajzikova","year":"2019","journal-title":"Cell Metab"},{"key":"2026012903565481000_BST-2025-3113C106","doi-asserted-by":"crossref","first-page":"19037","DOI":"10.1038\/s41598-022-23006-1","article-title":"Discovery of potential natural dihydroorotate dehydrogenase inhibitors and their synergism with brequinar via integrated molecular docking, dynamic simulations and in vitro approach","volume":"12","author":"Khairy","year":"2022","journal-title":"Sci. Rep."},{"key":"2026012903565481000_BST-2025-3113C107","doi-asserted-by":"crossref","first-page":"874","DOI":"10.2174\/1570159X14666161208151525","article-title":"From Leflunomide to Teriflunomide: Drug Development and Immunosuppressive Oral Drugs in the Treatment of Multiple Sclerosis","volume":"15","author":"Aly","year":"2017","journal-title":"Curr. Neuropharmacol."},{"key":"2026012903565481000_BST-2025-3113C108","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1021\/acs.jmedchem.0c01549","article-title":"Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Biphenyl Moiety","volume":"64","author":"Sainas","year":"2021","journal-title":"J. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C109","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.cell.2016.08.057","article-title":"Inhibition of dihydroorotate dehydrogenase overcomes differentiation blockade in acute myeloid leukemia","volume":"167","author":"Sykes","year":"2016","journal-title":"Cell"},{"key":"2026012903565481000_BST-2025-3113C110","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1107\/S2059798324004066","article-title":"An alternative conformation of the N-terminal loop of human dihydroorotate dehydrogenase drives binding to a potent antiproliferative agent","volume":"80","author":"Alberti","year":"2024","journal-title":"Acta Crystallogr. D. Struct. Biol."},{"key":"2026012903565481000_BST-2025-3113C111","doi-asserted-by":"crossref","first-page":"12701","DOI":"10.1021\/acs.jmedchem.2c00496","article-title":"Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety","volume":"65","author":"Sainas","year":"2022","journal-title":"J. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C112","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1021\/acs.jmedchem.5c00348","article-title":"Fluorescent Isostere (Fluostere) of the Carboxylate: Design of hDHODH Fluorescent Inhibitors as Proof of Concept","volume":"68","author":"Sainas","year":"2025","journal-title":"J. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C113","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1039\/C1MB05402C","article-title":"Molecular, kinetic and thermodynamic characterization of Mycobacterium tuberculosis orotate phosphoribosyltransferase","volume":"8","author":"Breda","year":"2012","journal-title":"Mol. Biosyst."},{"key":"2026012903565481000_BST-2025-3113C114","doi-asserted-by":"crossref","first-page":"140681","DOI":"10.1016\/j.bbapap.2021.140681","article-title":"Detection of an enzyme isomechanism by means of the kinetics of covalent inhibition","volume":"1869","author":"Adediran","year":"2021","journal-title":"Biochim. Biophys. Acta Proteins Proteom"},{"key":"2026012903565481000_BST-2025-3113C115","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejmech.2012.04.031","article-title":"Pyrimidin-2(1H)-ones based inhibitors of Mycobacterium tuberculosis orotate phosphoribosyltransferase","volume":"54","author":"Breda","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C116","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.molbiopara.2003.12.006","article-title":"Human malaria parasite orotate phosphoribosyltransferase: functional expression, characterization of kinetic reaction mechanism and inhibition profile","volume":"134","author":"Krungkrai","year":"2004","journal-title":"Mol. Biochem. Parasitol."},{"key":"2026012903565481000_BST-2025-3113C117","doi-asserted-by":"crossref","first-page":"34746","DOI":"10.1074\/jbc.M113.521955","article-title":"Transition State Analogues of Plasmodium falciparum and Human Orotate Phosphoribosyltransferases","volume":"288","author":"Zhang","year":"2013","journal-title":"Journal of Biological Chemistry"},{"key":"2026012903565481000_BST-2025-3113C118","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1021\/acsinfecdis.7b00006","article-title":"A Phenotypic based target screening approach delivers new antitubercular CTP Synthetase Inhibitors","volume":"3","author":"Esposito","year":"2017","journal-title":"ACS Infect. Dis."},{"key":"2026012903565481000_BST-2025-3113C119","doi-asserted-by":"crossref","first-page":"1329011","DOI":"10.3389\/fphar.2024.1329011","article-title":"A journey into the regulatory secrets of the de novo purine nucleotide biosynthesis","volume":"15","author":"Ayoub","year":"2024","journal-title":"Front. Pharmacol."},{"key":"2026012903565481000_BST-2025-3113C120","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3390\/molecules25051205","article-title":"Targeting Genome Integrity in Mycobacterium Tuberculosis: From Nucleotide Synthesis to DNA Replication and Repair","volume":"25","author":"Miggiano","year":"2020","journal-title":"Molecules"},{"key":"2026012903565481000_BST-2025-3113C121","doi-asserted-by":"crossref","first-page":"e15494","DOI":"10.1371\/journal.pone.0015494","article-title":"Mycobacterium tuberculosis phosphoribosylpyrophosphate synthetase: biochemical features of a crucial enzyme for mycobacterial cell wall biosynthesis","volume":"5","author":"Lucarelli","year":"2010","journal-title":"PLoS ONE"},{"key":"2026012903565481000_BST-2025-3113C122","doi-asserted-by":"crossref","first-page":"e0175815","DOI":"10.1371\/journal.pone.0175815","article-title":"Biochemical and structural investigations on phosphoribosylpyrophosphate synthetase from Mycobacterium smegmatis","volume":"12","author":"Donini","year":"2017","journal-title":"PLoS ONE"},{"key":"2026012903565481000_BST-2025-3113C123","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/j.1462-5822.2009.01325.x","article-title":"Hypoxia: a window into Mycobacterium tuberculosis latency","volume":"11","author":"Rustad","year":"2009","journal-title":"Cell. Microbiol."},{"key":"2026012903565481000_BST-2025-3113C124","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.chom.2014.11.016","article-title":"Stress and Host Immunity Amplify Mycobacterium tuberculosis Phenotypic Heterogeneity and Induce Nongrowing Metabolically Active Forms","volume":"17","author":"Manina","year":"2015","journal-title":"Cell Host Microbe"},{"key":"2026012903565481000_BST-2025-3113C125","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.2174\/092986711795029627","article-title":"Purine Salvage Pathway in Mycobacterium tuberculosis","volume":"18","author":"Ducati","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"2026012903565481000_BST-2025-3113C126","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1080\/22221751.2018.1559706","article-title":"Housecleaning of pyrimidine nucleotide pool coordinates metabolic adaptation of nongrowing Mycobacterium tuberculosis","volume":"8","author":"Shi","year":"2019","journal-title":"Emerg. Microbes Infect."},{"key":"2026012903565481000_BST-2025-3113C127","doi-asserted-by":"crossref","first-page":"e1011663","DOI":"10.1371\/journal.ppat.1011663","article-title":"Transposon sequencing reveals metabolic pathways essential for Mycobacterium tuberculosis infection","volume":"20","author":"Block","year":"2024","journal-title":"PLoS Pathog."},{"key":"2026012903565481000_BST-2025-3113C128","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/pathogens7010017","article-title":"Mycobacterium tuberculosis molecular determinants of infection, survival strategies, and vulnerable targets","volume":"7","author":"Ferraris","year":"2018","journal-title":"Pathogens"},{"key":"2026012903565481000_BST-2025-3113C129","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/s41586-025-09177-7","article-title":"Targeting de novo purine biosynthesis for tuberculosis treatment","volume":"644","author":"Lamprecht","year":"2025","journal-title":"Nature"},{"key":"2026012903565481000_BST-2025-3113C130","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.cmi.2023.07.013","article-title":"Recent advances in the treatment of tuberculosis","volume":"30","author":"Motta","year":"2024","journal-title":"Clin. Microbiol. Infect"},{"key":"2026012903565481000_BST-2025-3113C131","doi-asserted-by":"crossref","first-page":"114588","DOI":"10.1016\/j.biopha.2023.114588","article-title":"Advances in immunomodulatory strategies for host-directed therapies in combating tuberculosis","volume":"162","author":"Ayodele","year":"2023","journal-title":"Biomed. Pharmacother"},{"key":"2026012903565481000_BST-2025-3113C132","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/pathogens11111291","article-title":"Host-directed therapies for tuberculosis","volume":"11","author":"Jeong","year":"2022","journal-title":"Pathogens"},{"key":"2026012903565481000_BST-2025-3113C133","doi-asserted-by":"crossref","first-page":"a021196","DOI":"10.1101\/cshperspect.a021196","article-title":"Host-directed therapies for tuberculosis","volume":"5","author":"Tobin","year":"2015","journal-title":"Cold Spring Harb. Perspect. Med."}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/doi\/10.1042\/BST20253113\/983397\/bst-2025-3113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/doi\/10.1042\/BST20253113\/983397\/bst-2025-3113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T08:57:22Z","timestamp":1769677042000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/54\/1\/37\/237082\/Targeting-opportunities-presented-by-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":133,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,12]]},"published-print":{"date-parts":[[2026,1,28]]}},"URL":"https:\/\/doi.org\/10.1042\/bst20253113","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]}}}